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Agriculture Organization of the United Nations. High estimates claim 
that 50% of the pigs in that country have been lost, which is one-fourth 
of all pigs in the world.
“When you think about the world’s largest pork producer losing that 
many pigs, it significantly changes the global swine industry because 
China is now going to have to replace the pork that they are no longer 
able to produce,” said Megan Niederwerder, assistant professor of 
diagnostic medicine and pathobiology in the College of Veterinary 
Medicine.
In the U.S., the K-State Biosecurity Research Institute, or BRI, is the 
only university laboratory where researchers can study African swine 
fever virus, which is a biosafety level-3 pathogen. A significant amount 
of work with African swine fever also is being done at the Plum Island 
Animal Disease Center in New York. The center will be replaced by the 
National Bio and Agro-Defense Facility, which is under construction 
adjacent to the K-State Manhattan campus.
The K-State research, which includes partnerships with other universities 
and private industry, involves experts who study the traits of the 
virus, the host’s immune system, potential vaccines, animal husbandry, 
international trade, movement of materials associated with the virus and 
more. Research takes place both in countries where African swine fever 
is present and in the safe research space at the BRI. 
“In order to control most viruses, you need a multipronged approach,” 
said Jürgen A. Richt, Regents distinguished professor in the College of 
Veterinary Medicine. “This is also the basis for all of these foreign or 
transboundary animal diseases. It doesn’t matter whether it’s African 
swine fever, classical swine fever, foot-and-mouth disease, Rift Valley 
fever or others.”
The American heartland is just a little less than 11,000 miles from 
Beijing … a distant world away, it seems. Yet, in Manhattan, Kansas, 
several Kansas State University scientists focus daily on the Chinese city.
China, which once raised more than half of the world’s approximately 
1.5 billion pigs, is the center of the current outbreak of African swine 
fever virus that has affected multiple countries in Africa, Asia and 
Europe, according to the World Organization for Animal Health.
The disease has never been reported in the U.S., which is the second 
largest country for pork production and raised approximately 70 million 
animals in 2019. Humans cannot contract African swine fever and pork 
from infected animals is safe to eat.
But for pigs, the African swine fever virus is bad news. There are no 
vaccines to prevent the highly contagious and deadly disease, which 
causes high fever, loss of appetite and other clinical signs in infected 
animals. Government officials have enforced strict biosecurity barriers to 
slow the spread of the virus.
“We compare African swine fever to lava,” said Cassie Jones, associate 
professor of animal sciences and industry in the College of Agriculture 
and a swine nutritionist with K-State Research and Extension. “There 
are some pathogens that are more like a volcano, where there is just 
an explosion of virus. African swine fever is more like the flow of lava, 
where it is a slow flow of disease, but you can’t stop it. It seems like no 
matter what we do in the countries that have been struggling with it, as 
soon as a herd gets contaminated or infected, it just continues to slowly 
spread. It’s very difficult to contain.”
China’s losses since the virus was first detected in August 2018 
have topped $50 billion, according to estimates from the Food and 
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Safe and effective
Through industry partnerships, K-State scientists are conducting African 
swine fever virus vaccine development work. One project involves 
a sponsored research agreement facilitated by K-State Innovation 
Partners and MEDIAN Diagnostics Inc., or MDx, a veterinary medicine 
company based in South Korea. 
“The technology we are utilizing is based on a novel adenovirus 
backbone — developed from human adenovirus serotype 6 — that can 
amplify a transgene up to 10,000 copies in the infected cell without 
producing infectious viruses,” said Waithaka Mwangi, professor of 
diagnostic medicine and pathobiology in the College of Veterinary 
Medicine.
Mwangi said that the single-cycle adenovirus vaccine platform can 
safely induce more robust and persistent immune responses compared 
to live, inactivated and subunit vaccines that are traditionally used. This 
platform was originally developed at the Mayo Clinic.




Niederwerder focuses on ways that foreign animal diseases, such 
as African swine fever, could be introduced through feed and feed 
ingredients. Swine feed often consists of many ingredients, such as amino 
acids, vitamins, vegetable proteins or grains, to give the pig the nutrition 
it needs.
“One of the first parts of our work was to discover if the virus is stable 
in feed and feed ingredients that have been subjected to fluctuating 
humidity and temperature conditions during shipment,” Niederwerder 
said. “The U.S. imports millions of kilograms of feed ingredients from 
countries that may have circulating foreign animal disease. These 
ingredients are incorporated into swine diets, provided to pigs for 
consumption and could potentially serve as a route for the spread of 
transboundary animal disease.”
One major finding indicated that the African swine fever virus can 
indeed survive the boat ride across an ocean, where it could be 
introduced into feed provided to animals. The bottom line: This virus 
is stable enough to survive a simulated transport from Beijing to Des 
Moines, Iowa. 
“That’s not a big surprise to us, but what we want to know now is if 
a virus makes its way into a contaminated ingredient, does that get 
distributed through an entire batch of feed and through the entire 
feed manufacturing environment, or does it tend to stay in pockets of 
contamination?” Jones said. “Knowing that has some really meaningful 
implications of whether the entire feed supply chain is contaminated, or 
if we have a risk area, and how careful we need to be about biosecurity 
and subsequent uses of equipment or trucks.”
Researchers also are working on methods to decontaminate and clean 
infected feed. Niederwerder has conducted a study that indicates that the 
half-life of African swine fever — or the amount of time it takes for the 
virus to decay by one-half — is between 9.6 and 14.2 days.
“Defining the timeline for how a virus decays naturally in feed allows us 
to consider storage periods for feed ingredients after they arrive to the 
U.S. from high-risk countries,” Niederwerder said. 
That information also could help researchers establish guidelines for 
using thermal treatments or antiviral chemical mitigants, she said.
Diagnostics and vaccines
Richt’s work includes developing tools to diagnose the disease quickly as well as 
developing vaccines.
“The earlier you diagnose a foreign animal disease, the earlier you can stop its spread,” 
he said. “If you can detect the disease 24 hours earlier, how many animals can you save? 
How many millions of dollars can you save?”
For African swine fever, Richt’s group has partnered with Silver Lake Research Corp. of 
Azusa, California, to develop a point-of-care diagnostic test that is the first of its kind in 
the U.S. The test, called PenCheck, can be used right in the field with a simple drop of 
blood from a pig.
“It’s very simple, very fast and very accurate,” Richt said. 
The test was developed and tested in the BRI and it is being validated by the Food and 
Agriculture Organization of the United Nations. Many other tests to increase the speed 
of diagnosis are underway, but are not yet ready for market, he said.
It will take a while to develop vaccines to provide immunity to pigs, Richt said. The first 
licensed vaccine for African swine fever may not be available for another three to five 
years.
“We do not know a lot about the basic functions and replication strategies, or the 
immunosuppressive functions of this virus,” he said. “When we talk about African swine 
fever, we often compare it to classical swine fever and foot-and-mouth disease. The 
genome of the African swine fever virus is 15 to 20 times the size of those agents. Also, 
the African swine fever virus expresses more than 150 viral genes, but we only know 
about 30 of those in detail, or about 20%. So, right now this virus is very effective in 
undermining the immune system of pigs.”
The K-State researchers agree: Collaboration is key to fighting African swine fever and 
other devastating diseases worldwide. 
“Worldwide, we’re already having big conversations in agriculture about how we are 
going to feed 9.8 billion people by the year 2050,” Niederwerder said. “These diseases 
significantly impact the health of food-producing animals and our ability to provide 
protein for humans.”
